news - DOSIsoft

SNMMI Annual Meeting 2025

April 7, 2025

The SNMMI (Society of Nuclear Medecine and Molecular Imaging) Annual Meeting
June 21-25, 2025
New Orleans, LA USA
Booth #1503

A Collapsed Cone Convolution Dose Engine Suitable for Secondary Dose Check and Patient QA Tasks in Online Adaptive Workflows

April 2, 2025

ThinkQA Secondary dose check solution relies on its modern dose calculation engine, an up-to-date point kernel Collapsed Cone Convolution (CCC) algorithm and implementation, tailored to comply with the specific requirements of online adaptive radiotherapy, including the Elekta Unity MR-linac specific considerations. The CCC dose engine is also a key component of a wider Patient-specific Quality Assurance solution, which becomes a mandatory element of modern online adaptive treatment workflows, using either MR- or CT-linacs.

ESTRO Annual Congress 2025

April 2, 2025

European SocieTy for Radiotherapy & Oncology (ESTRO) Annual Meeting
May 2-6, 2025
Vienna, Austria
Booth #470

[Article] Commissioning of a Commercial Secondary Dose Check Software and Clinical Implementation for the Magnetic Resonance‑guided Linear Accelerator Adaptive Workflow

April 2, 2025

José Alejandro Rojas‑López, Alexis Cabrera‑Santiago, Jorge Ramiro Corral‑Beltrán, Albin Ariel García-Andino
J Med Phys 2025;50:20-9. | DOI: 10.4103/jmp.jmp_150_24

[Poster] Puesta en Marcha de un Sistema de Cálculo Secundario de Dosis para un Acelerador Lineal con Resonancia Magnética*

April 2, 2025

*Implementation of a Secondary Dose Calculation System for a Magnetic Resonance Linear Accelerator
Rojas-López JA, Cabrera-Santiago A, Corral-Beltán JR, García-Andino AA
Presented at ALFIM 2025

Turkish Society for Nuclear Medicine Annual Congress 2025

April 1, 2025

Turkish Society for Nuclear Medicine Annual Congress
April 9-13, 2025
Antalye, Turkey

DOSIsoft Announces New FDA 510(k) Clearance for PLANET® Onco Dose

March 25, 2025

DOSIsoft, SA is proud to announce its latest product release, PLANET® Onco Dose version 3.2 received FDA 510(k) Clearance on March 14, 2025 from the US Food and Drug Administration, following its EU MDR CE Mark certification. The novel PLANET® platform is designed to incorporate a multi-radionuclide approach, implement multi-workflow solutions, and support multi-therapy applications for both SIRT (Selective Internal Radiation Therapy) and MRT (Molecular Radiation Therapy) while ensuring compliance with U.S. standards.

PLANET® Onco Dose Receives EU MDR CE Mark certification

March 4, 2025

DOSIsoft is proud to announce that its latest product release, PLANET® Onco Dose version 3.2 – multi-radionuclide, personalized, voxel-based dosimetry platform for both SIRT and MRT – received Medical Device Regulation (MDR) CE Mark on February 17, 2025, under the new (EU) Regulation 2017/745.

JFMN 2025

February 14, 2025

11th Annual Congress of JFMN (Journées Francophones de Médecine Nucléaire)
March 20-22, 2025
Montrouge, France
Booth #6a

ALFIM Congress 2025

February 13, 2025

10th Latin American Congress of Medical Physics (ALFIM)
March 9-12, 2025
La Antigua, Guatemala
Patient QA showcase on Elekta booth